ALK and neuroblastoma: Neuroblastoma is a complex heterogeneous disease exhibiting a variety of characteristic patterns of genetic aberrations that correlate with clinical outcome, of which cases with ALK mutation and MYCN amplification are more aggressive in nature (De Brouwer et al., 2010).